Cita APA

Rao, R., Lee, P., Fiskus, W., Yang, Y., Joshi, R., Wang, Y., . . . Bhalla, K. N. (2009). Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: A highly active combination against human Mantle Cell Lymphoma (MCL) cells.

Citación estilo Chicago

Rao, Rekha, et al. Co-treatment With Heat Shock Protein 90 Inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and Vorinostat: A Highly Active Combination against Human Mantle Cell Lymphoma (MCL) Cells. 2009.

Cita MLA

Rao, Rekha, et al. Co-treatment With Heat Shock Protein 90 Inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and Vorinostat: A Highly Active Combination against Human Mantle Cell Lymphoma (MCL) Cells. 2009.